(EMAILWIRE.COM, February 20, 2018 ) Chlamydia is a sexually transmitted disease. The symptoms do not occur early on. It is usually prevalent in areas with poor sanitation. It is the most common STD worldwide. Number of victims has been increasing over the last decade.The Latin America Chlamydia Infection Diagnostics and Therapeutics market size was around USD 240 million in 2017. It is expected to grow at a CAGR of 6.5% to reach USD 330 million by 2022. It captures 12% of the global market.

Increasing number of cases of these diseases better and complete reporting in emerging economies, augmenting screening coverage, improved funding for better R&D in this area, growing awareness regarding STDs in the developing countries along with the increased healthcare expenditures are the factors driving the growth of this market. Also accessibility to and availability of hyper sensitive diagnostic tests are also boosting the growth of this market. Furthermore, improved insurance coverage in the emerging economies augurs well for this market.However, the stigma associated with sexually transmitted diseases is the primary restraint of market growth.

Get free research sample at https://www.marketdataforecast.com/market-reports/latin-america-chlamydia-infection-diagnostics-and-therapeutics-market-5146/request-sample

This market is broadly segmented by product type and end user into diagnostics and therapeutics segments. Classification in diagnostics by product type entails Nucleic Acid Amplification Tests (NAATs), Direct Fluorescent Tests, and PCR. NAAT accounted for the largest market share in 2016 and is predicted to grow robustly in the forecast period. It is closely tailed by DFT in terms of CAGR. This is because NAATs are more sensitive and diagnose better. Classification in diagnostics by end user entails Hospitals, Specialty Clinics, and Diagnostic Centres. Classification in therapeutics by product type entails Macrolides, Quinolones, Sulphonamides, Tetracycline, and Aminopenicillins. Macrolides is expected to undergo high growth in the forecast period. It also captures the largest market share and is expected to stay at the top in the forecast period. Classification in therapeutics by end user entails Hospital Pharmacies, Drugstores, Retail Pharmacies, and Online Pharmacies.

Classification by geography entails Brazil, Chile, Argentina and others. It is the second fastest growing market but is second to last in terms of revenue generation. Brazil leads this market.

Key players in the market include Bio Rad laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher. Other players in the market include bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Company.

The scope of the report provides:

The evaluation of the current market for your product or services and the future implications of the market

Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future

Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment

Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share

The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces

The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors

Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments

Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence

Equip you with the information providing with the investment opportunities in the industry

Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.

About Market Data Forecast

Being a familiar face to the Fortune 500 companies in the field of market research, Market Data Forecast provides its clientele with research material through syndicated reports, consult projects and industry newsletters across various domains and verticals. Our in-house research panel, comprises of industry experts, vertical/domain specialists, supported by a well-built research & data models that help in providing insights for making well-informed decisions. We have a well-established data gathering network across 100+ countries through tie-ups and collaboration’s with the key personnel in value chains & local research organizations. Apart the excellent research services, we also boast of unique post-purchase services offering a 24*7 analyst support for the period of six months. Further, though a continuous feedback from our users, clients and experts, we keep on innovating ourselves in this field to support the organizations in the most efficient ways.

Contact Information:
Market Data Forecast
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results